Pharmacy Practice Important Questions for B.Pharm 7th Sem (Unit-wise, BP703T)

By Vignesh, Pharma Graduate · Member of LBP · Updated November 2026

Pharmacy Practice looks easy because it reads like common sense, but marks are lost when answers lack structure: the classification of ADRs, the steps of a drug distribution system, the members of a P&T committee. Examiners look for these specific points.

This guide lists the Pharmacy Practice important questions for B.Pharm 7th sem, unit by unit, following the PCI syllabus (BP703T). The ★ questions are the ones that appear most often, and two sample answers show you how to write them.

Want every answer written out? The Pharmacy Practice Exam Pack has model answers for all the ★ questions. Just ₹49. See the pack →

Pharmacy Practice exam pattern (BP703T)

Section	Questions	Marks
I. Objective (MCQs / fill in the blanks / one-word)	10 × 2 (or 20 × 1)	20
II. Long answers	Answer 2 of 3 × 10	20
III. Short answers	Answer 7 of 9 × 5	35
Total	3 hours	75

Pharmacy Practice rewards lists and diagrams. A labelled hospital pharmacy layout or a flow chart of the unit-dose system earns marks quickly.

Pharmacy Practice important questions, unit-wise

★ marks the questions asked most often in university papers. Prepare these first.

Unit I: Hospital, hospital pharmacy, ADRs, community pharmacy

Long (10 marks)

• ★ Define hospital. Classify hospitals and describe their organisation. Describe the organisation, functions, location and layout of a hospital pharmacy.
• ★ Define adverse drug reaction. Classify ADRs. Explain the detection, reporting and management of ADRs (PvPI).

Short (5 marks)

• ★ Staffing and workload of a hospital pharmacy · Predisposing factors for ADRs · Naranjo scale
• ★ Community pharmacy: organisation, structure, legal requirements, management (finance, materials, staff, infrastructure)

Unit II: Drug distribution, formulary, TDM, adherence, medication history

Long

• ★ Describe the drug distribution systems for in-patients in hospitals, with emphasis on the unit dose drug distribution system.
• ★ Define therapeutic drug monitoring. Explain its need, the drugs requiring TDM, and the role of the pharmacist.

Short

• ★ Hospital formulary: contents, preparation, revision · Dispensing to out-patients · Dispensing of controlled drugs
• ★ Medication adherence: causes of non-adherence and methods of improving it · Patient medication history interview

Unit III: PTC, drug information, patient counselling, education

Long

• ★ Describe the Pharmacy and Therapeutics Committee: composition, objectives and functions.
• ★ Define patient counselling. Describe the steps of patient counselling, the barriers and the role of the pharmacist.

Short

• ★ Drug information services: sources (primary, secondary, tertiary), steps in answering a query
• Education and training programmes in the hospital · Communication skills · Prescribed medication order (interpretation and legal requirements)

Unit IV: Budget, clinical pharmacy, OTC

Short

• ★ Clinical pharmacy: introduction, scope, functions of the clinical pharmacist (ward rounds, medication review)
• ★ OTC sales: role of the pharmacist in OTC medication and rational use · Budget preparation and implementation

Unit V: Inventory control, investigational drugs, laboratory tests

Long / short

• ★ Explain drug store management and inventory control: purchase procedures, ABC, VED, EOQ, lead time, safety stock, reorder level
• ★ Investigational use of drugs in hospitals
• ★ Interpretation of clinical laboratory tests: blood chemistry (glucose, urea, creatinine, LFT, lipids, electrolytes), haematology (CBC, ESR), urinalysis

Sample model answers

Here are 2 answers written the way examiners like them. The pack has model answers for every ★ question.

Medication adherence (5 marks)

Definition (WHO, 2003): “the extent to which a person’s behaviour – taking medication, following a diet and/or executing lifestyle changes – corresponds with agreed recommendations from a healthcare provider.” (Compliance implies passive obedience; adherence implies agreement between the patient and provider; concordance is a shared decision.)

Types of non-adherence:

• Primary non-adherence: the prescription is never filled.
• Secondary: the drug is taken incorrectly (missed doses, wrong dose or time, stopping early, taking extra doses, drug holidays).
• Intentional (the patient decides: fear of side effects, feeling better) vs unintentional (forgetfulness, misunderstanding).

Causes (WHO’s five dimensions):

1. Patient-related: forgetfulness, lack of knowledge about the disease, beliefs and attitudes (fear of addiction, not believing in the treatment), cognitive impairment, depression, old age, substance abuse, poor vision or dexterity.
2. Therapy-related: complex regimens (many drugs, frequent dosing), adverse effects, long duration (chronic diseases), asymptomatic disease (hypertension, hyperlipidaemia), unpleasant taste, difficult dosage forms (inhalers, injections), immediate benefit not felt.
3. Condition-related: chronic and asymptomatic diseases, psychiatric illness, severity of symptoms, disability.
4. Healthcare system / provider-related: poor communication, inadequate counselling, short consultation time, poor follow-up, lack of access to medicines, frequent changes of brands.
5. Socioeconomic: cost of medicines, poverty, illiteracy, lack of social support, distance to the pharmacy, cultural beliefs.

Consequences: treatment failure, disease progression, hospital readmissions, drug resistance (antibiotics, TB, HIV), increased healthcare costs, wrong dose escalation, and death.

Measurement of adherence:

• Direct methods: drug or metabolite levels in blood or urine; markers; directly observed therapy (DOTS).
• Indirect methods: pill counts, patient self-report / questionnaires (Morisky Medication Adherence Scale, MMAS-8), pharmacy refill records (medication possession ratio, MPR), electronic monitoring (MEMS caps), clinical response.

Methods to improve adherence:

• Patient counselling and education (about the disease, the drug, its benefits and side effects).
• Simplify the regimen: fewer doses per day (once-daily, sustained-release forms), fixed-dose combinations.
• Adherence aids: pill organisers (dosette boxes), calendars, blister (calendar) packs, reminders (alarms, SMS, apps), pictograms on labels.
• Written information in the patient’s language; large-print labels.
• Involve family and caregivers.
• Regular follow-up; monitoring and feedback; motivational interviewing.
• Reduce costs (generics, Jan Aushadhi, government schemes).
• Manage side effects proactively.
• Build a good patient–provider relationship (shared decision making).

Role of the pharmacist: identify non-adherent patients (refill records, interviews), counsel, simplify regimens with the doctor, provide adherence aids, follow up, and educate about the importance of adherence.

Hospital formulary (5 marks)

Definition: a continually revised compilation of pharmaceuticals (and important ancillary information) that reflects the current clinical judgement of the medical staff of the hospital. It is prepared by the Pharmacy and Therapeutics Committee.

Objectives: promote rational, safe and cost-effective drug therapy; limit the number of drugs (avoid duplication); provide drug information to staff; aid inventory control and purchasing; and serve as an educational tool.

Contents (organisation of the formulary):

1. Information on hospital policies and procedures concerning drugs:
   • the PTC: its members, functions and policies;
   • hospital regulations on prescribing, dispensing and administering drugs;
   • the procedure for adding or deleting drugs and for non-formulary drug requests;
   • pharmacy operating procedures (hours, out-patient services, drug information service);
   • generic substitution policy; ADR reporting procedure; the use of investigational drugs.
2. The drug list (main section): drugs arranged by therapeutic class (or alphabetically), with generic name, synonyms or brand names, dosage forms, strengths, packaging, cost, and usual doses; possibly also indications, contraindications, ADRs, precautions and restricted-use status.
3. Special information:
   • Index (generic and brand names; therapeutic index).
   • Tables: dose calculations (paediatric, renal), IV compatibility, antidotes and poison control, drug interactions, abbreviations, conversion tables, normal laboratory values, sodium content of drugs, nutritional products, and contents of emergency kits.

Preparation and revision:

• The PTC selects drugs on the basis of efficacy, safety, cost, quality and need; the chief pharmacist (secretary of the PTC) compiles the formulary.
• Physicians may request additions using a formulary request form.
• It is revised periodically (usually annually), with supplements or electronic updates between editions.
• Format: printed pocket-sized booklet, loose-leaf, or electronic (in the hospital information system).

Advantages: standardised and rational prescribing; cost savings (bulk purchase, fewer brands); less inventory; quick drug information; fewer medication errors; educational value.

5 practice MCQs with answers

1. The secretary of the Pharmacy and Therapeutics Committee is usually the:

• a) Medical superintendent
• b) Chief pharmacist
• c) Nursing superintendent
• d) Hospital administrator

Show answer

Answer: b. A senior physician is the chairman.

2. The hospital formulary is prepared by the:

• a) Ethics committee
• b) Purchase committee
• c) Infection control committee
• d) Pharmacy and Therapeutics Committee

Show answer

Answer: d. It is revised periodically, usually annually.

3. In the unit dose drug distribution system, the supply on the ward at any time is usually not more than:

• a) 3 days
• b) 1 week
• c) 6 hours
• d) 24 hours

Show answer

Answer: d. Doses are dispensed in single-unit, ready-to-administer packages.

4. The drug distribution system with the highest risk of medication errors and pilferage is:

• a) Complete floor stock system
• b) Individual prescription system
• c) Decentralised unit dose system
• d) Unit dose system

Show answer

Answer: a. No pharmacist reviews the orders.

5. A dose-related, predictable ADR is classified as:

• a) Type D
• b) Type E
• c) Type A
• d) Type B

Show answer

Answer: c. Type A reactions are augmented pharmacological effects.

Free Pharmacy Practice notes, unit-wise

• Unit 1: Hospital and hospital pharmacy
• Unit 2: Drug distribution, P&T committee, drug information
• Unit 3: Medication adherence, counselling, TDM
• Unit 4: Budget, inventory and drug store management
• Unit 5: Investigational drugs, lab tests, OTC

Related guides

• Industrial Pharmacy 2 important questions

Frequently asked questions

What are the most important topics in Pharmacy Practice?

Hospital pharmacy organisation, drug distribution systems, adverse drug reactions, the Pharmacy and Therapeutics Committee, therapeutic drug monitoring, patient counselling and inventory control.

Is Pharmacy Practice an easy subject in 7th sem?

It is one of the more scoring Semester 7 papers because it is descriptive. You still need the exact classifications and steps; generic answers score low.

Which ADR classification should I write?

Write Rawlins and Thompson (Type A to F) with an example for each, then detection, reporting (PvPI) and management. That covers most ADR questions.

Do these questions follow the PCI syllabus?

Yes, they follow the PCI B.Pharm syllabus for BP703T. Universities may change the marks split, so check a recent paper from your university.